News

Two Compelling Growth Stocks Available at a Discount

Two Compelling Growth Stocks Available at a Discount

The financial market has seen wild swings, leaving some stocks looking like prime bargains. You gotta sift through the chaos and dig into what makes these companies tick before jumping in. One sector to keep an eye on is medical tech—specifically DexCom (NASDAQ: DXCM), a player that’s been catching heat but might just be ripe for a buy-the-dip strategy.

DexCom's Position: A Sugar-Coated Bargain?

DexCom's continuous glucose monitoring (CGM) devices are crucial for folks managing diabetes. Yet, the stock took a nosedive of about 45%, sparking chatter on the desks—buying opportunity or sinking ship? Sure, recent challenges loom large, especially with GLP-1 agonist medications stealing some thunder by showing impressive results in diabetes management and weight loss. But here's where it gets interesting: CGMs aren't going anywhere. They provide real-time data that those new meds just can't replace.

Market Dynamics at Play

Diving deeper into DexCom’s numbers reveals resilience amidst chaos. They've held onto strong profitability while raking in revenue even as their stock price wobbled like a rookie trader on his first day. The company recently unveiled Stelo, an over-the-counter glucose biosensor designed to cater to 125 million Americans with type 2 diabetes who don’t rely on insulin shots—great move! It expands their market reach and improves accessibility without breaking the bank.

Bill Holdings: Tech’s Financial Game Changer?

Now shift your gaze to Bill Holdings (NYSE: BILL). This company offers financial automation software tailored for small to mid-sized businesses, facing its own storm with a stock decline of around 32%. But don't let that scare ya off—it’s more about broader market volatility than any glaring missteps from Bill itself.

The business model here is solid gold; they optimize financial operations with automation that tackles everything from invoicing to payment collection. With subscription fees making up a big chunk of revenue, they're banking on loyal clients—which seems smart given their year-over-year revenue spike of 22%. That’s no joke when you consider they've got nearly 475,000 businesses relying on their services.

A savvy trader would look at these fundamentals rather than panic over the price drop—those numbers tell a story worth listening to.

Investors should take note that Bill remains net income positive even when factoring in non-GAAP metrics—a sign they’re doing something right in this tough environment. They’re not just surviving; they’re thriving despite competition trying to nab their lunch money.

The Bigger Picture: Are These Stocks Worth Your Cash?

If you're looking for opportunities amid all this noise, DexCom and Bill Holdings could be your golden ticket back into growth stocks without paying full price. Both have strong foundations that'll likely support recovery as the market settles down again post-fluctuations.

  • Market Reach: DexCom continues expanding its offerings while maintaining dominance in the CGM space.
  • Sustained Growth: Bill Holdings shows impressive growth metrics which stand out against broader trends affecting tech stocks.

This brings us back to what really matters—the fundamentals behind each ticker symbol are screaming “buy” if you can stomach the short-term volatility while waiting for long-term rewards. Remember how traders usually react when faced with uncertainty? Many run scared instead of considering solid plays at discounted rates!

You know how it goes; markets ebb and flow like waves crashing against rocks—a tough ride sometimes—but identifying undervalued players can lead to significant payoffs once calm returns. So whether you believe it's time to dip your toes or go all-in on DexCom or Bill Holdings depends entirely on your appetite for risk and horizon outlooks—but trust me, both have enough firepower under them that turning away feels foolish right now!

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Newegg’s GIGABYTE Event Is Brand Work, Not a Catalyst

Updated Category News Views 530

A 2,300-square-foot room can tell a retailer plenty about its tribe. On November 21, Newegg is turning its Diamond Bar Gamer Zone into the home base for GIGABYTE’s AORUS VS40 celebration, a free five-hour event marking the hardware maker’s 40th anniversary. There will be 1v1 VALORANT and League of Legends contests, demo stations, raffles, anniversary merchandise, food...

Continue Reading
UAE Ties Diplomacy, Media and AI Into a Shared Signal

Updated Category News Views 128

Influence is getting harder to measure, and easier to squander, which is why the message from Ajman deserves more than a polite nod. At the 2026 Ajman Media Forum, THE SIGNAL, Foreign Affairs Undersecretary Omar Obaid Alhesan Alshamsi made the UAE’s position plain: diplomacy and media are no longer separate lanes. Both operate on words, context, trust and the difficult...

Continue Reading
Anthropic's Leveraged ETFs Arrive After Wild Debut

Updated Category News Views 731

Nothing says a feverish new listing quite like leveraged products lining up before the opening-week confetti has settled. Anthropic priced its IPO at $83 on November 18, raised roughly $81.3 billion, then opened Nasdaq trading at $111.50 on November 19. That is an enormous gap between IPO price and first trade, and it tells investors the obvious thing: plenty of appetite...

Continue Reading
Fractional CIOs Bring Order to Growing Technology Chaos

Updated Category News Views 270

A company can outgrow its technology habits long before anyone notices the smoke. One day the owner is approving another software subscription, the office manager is chasing an internet provider, and the tech person is putting out password fires. None of that looks dramatic in isolation. Together, it is a business operating without a map. That is the useful point in the...

Continue Reading
PHONO's 150 MW RE+ Win Tests Its U.S. Solar Staying Power

Updated Category News Views 534

A trade-show order book is not cash in the bank, but 150 MW is still a number worth circling in red. PHONO used RE+ 2026 in Las Vegas, held November 17 through 19, to celebrate 20 years in business, parade its solar and storage lineup, and announce new U.S. orders. In a solar market that has become touchier about provenance, compliance and delivered economics, the company...

Continue Reading
Cardiovalve's Three-Year Data Clears a Crucial EU Hurdle

Updated Category News Views 98

A failing tricuspid valve is not a spreadsheet problem, and that matters before anybody gets carried away with a glossy conference presentation. Venus Medtech's Cardiovalve unit has reported results from TARGET in a population that was old, sick and largely out of good surgical options. That is precisely where a less invasive replacement therapy has to prove it can do...

Continue Reading
Persistent Dry Eye Symptoms Call for a Closer Look

Updated Category News Views 332

Eyes can turn into a stubborn little nuisance long before people realize something more complicated is going on. A bottle of artificial tears is easy to grab, cheap enough, and often perfectly sensible for a rough day of screens, wind, reading, or air conditioning. But Dr. Harlan Snyder’s point is the one worth sitting with: when dryness keeps barging back despite...

Continue Reading
ModuleMD Takes Allergy EHR AI Beyond the Usual Hype Cycle

Updated Category News Views 398

Allergy Workflows Are Where This Has to Earn Its Keep Allergy clinics do not need another shiny dashboard clogging up a workstation. They need less typing, fewer handoffs, cleaner documentation, and fewer administrative chores slipping through the cracks while a packed day keeps moving. That is the practical lens for ModuleMD's ACAAI 2026 presentation in Phoenix: not...

Continue Reading
FASTEN Data Offers an Early Look at Ladera Closure

Updated Category News Views 137

Femoral access may be the unglamorous part of a valve procedure, but it is where an otherwise tidy case can turn ugly in a hurry. That makes Ladera Medical's full FASTEN data worth a careful look. The company reported results in 55 patients undergoing transfemoral TAVR/TAVI, and the numbers presented at London Valves 2026 suggest its large-bore closure system may address...

Continue Reading
Global Child Tests Purpose Travel's Expanding Media Reach

Updated Category News Views 45

Celebrity travel programming usually melts into the wallpaper, but Global Child is trying to make the scenery answer for itself. Its new season of Global Child “Travel & Purpose” puts Andrea Bocelli in Tuscany, Isabela Merced in Peru and John Malkovich in Croatia, while tying each destination to a broader local-good mission. That is a more thoughtful pitch than...

Continue Reading

Top 5 Most Recently Viewed Articles

Exploring the Innovative CORDStrom™ Platform by INmune Bio

Updated Category News Views 200

Introduction to CORDStrom™ and Its Significance INmune Bio, Inc. (NASDAQ: INMB), a pioneer in the field of inflammation and immunology therapies, has recently sparked significant interest in the medical community. Their intriguing CORDStrom™ platform signifies a promising advance in mesenchymal stromal cell (MSC) therapies, aiming to address various health conditions...

Continue Reading
Brooklyn Law School Enhances Scholarship Support for Veterans

Updated Category News Views 156

Brooklyn Law School Expands Support for Veteran Students Brooklyn Law School has taken significant steps to demonstrate its commitment to veterans by increasing scholarship support, ensuring they receive the assistance they need to excel in their legal education. This initiative reflects a profound recognition of the sacrifices made by our armed forces members and aims to...

Continue Reading
Unlocking Creativity with the New vivo X200 FE Smartphone

Updated Category News Views 441

Introducing the vivo X200 FE: Ideal for the Innovative Generation Vivo proudly announces the launch of the X200 FE, a cutting-edge smartphone designed with the vibrant essence of the new generation in mind. This model combines playful aesthetics with dependable functionality, delivering an exceptional user experience. With its striking color-blocking design and advanced...

Continue Reading
Exploring Market Sentiment Towards Westinghouse Air Brake Tech

Updated Category News Views 201

Current Sentiment Around Westinghouse Air Brake Technologies Corp Westinghouse Air Brake Technologies Corp (NYSE: WAB) is a prominent player in the transportation industry, particularly known for its innovation in braking systems and other technology. Recently, it has come to light that the short interest as a percentage of its float has decreased significantly, by...

Continue Reading
Asante Gold Highlights Shareholder Meeting Information and Voting

Updated Category News Views 165

Key Information about Asante Gold's Upcoming Shareholder Meeting Your participation is crucial, regardless of how many shares you own in Asante Gold. The Company’s Board of Directors strongly advises all shareholders to vote for all resolutions presented. Proxy Materials Available Online Asante Gold Corporation (TSXV: ASE | GSE: ASG | OTCQX: ASGOF) has announced that...

Continue Reading